Massimo Falconi
#115,642
Most Influential Person Now
Researcher
Massimo Falconi's AcademicInfluence.com Rankings
Massimo Falconicomputer-science Degrees
Computer Science
#4499
World Rank
#4746
Historical Rank
Machine Learning
#900
World Rank
#913
Historical Rank
Artificial Intelligence
#1115
World Rank
#1135
Historical Rank
Database
#1714
World Rank
#1798
Historical Rank
Download Badge
Computer Science
Massimo Falconi's Degrees
- PhD Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Massimo Falconi Influential?
(Suggest an Edit or Addition)Massimo Falconi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. (2004) (2432)
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After (2017) (2307)
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. (2012) (2049)
- Whole genomes redefine the mutational landscape of pancreatic cancer (2015) (1983)
- International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas (2006) (1918)
- Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) (1556)
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system (2006) (1419)
- Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial (2001) (998)
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors (2016) (934)
- MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. (2006) (777)
- Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection (2004) (747)
- Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (616)
- Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. (2010) (493)
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors (2011) (480)
- TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. (2012) (429)
- Reconstruction by Pancreaticojejunostomy Versus Pancreaticogastrostomy Following Pancreatectomy: Results of a Comparative Study (2005) (421)
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients (2010) (414)
- Mucinous Cystic Neoplasm of the Pancreas is Not an Aggressive Entity: Lessons From 163 Resected Patients (2008) (410)
- European evidence-based guidelines on pancreatic cystic neoplasms (2018) (401)
- Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. (2005) (394)
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2020) (373)
- Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. (2007) (351)
- Identification of a novel antibody associated with autoimmune pancreatitis. (2009) (344)
- A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
- Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary (2007) (297)
- Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. (2010) (294)
- Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? (2006) (291)
- Amylase Value in Drains After Pancreatic Resection as Predictive Factor of Postoperative Pancreatic Fistula: Results of a Prospective Study in 137 Patients (2007) (289)
- Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. (2011) (284)
- Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. (2003) (283)
- Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. (2010) (282)
- Pancreatic Fistula Rate after Pancreatic Resection (2004) (267)
- Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. (2011) (261)
- Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma (2007) (256)
- Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) (2015) (253)
- Alcohol and Smoking as Risk Factors in Chronic Pancreatitis and Pancreatic Cancer (1999) (250)
- Management of Complications after Pancreaticoduodenectomy in a High Volume Centre: Results on 150 Consecutive Patients / with Invited Commentary (2002) (249)
- Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma (2007) (239)
- Middle Pancreatectomy: Indications, Short- and Long-term Operative Outcomes (2007) (224)
- Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. (2008) (215)
- Pancreatic insufficiency after different resections for benign tumours (2007) (215)
- Autoimmune Pancreatitis: Differences Between the Focal and Diffuse Forms in 87 Patients (2009) (211)
- Efficacy of octreotide in the prevention of complications of elective pancreatic surgery (1994) (211)
- Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis (2001) (210)
- Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. (1998) (205)
- Incidence of cancer in the course of chronic pancreatitis (1999) (200)
- Management of 100 Consecutive Cases of Pancreatic Serous Cystadenoma: Wait for Symptoms and See at Imaging or Vice Versa? (2003) (199)
- Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. (2013) (192)
- Efficacy of octreotide in the prevention of complications of elective pancreatic surgery (1994) (189)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours (2017) (186)
- Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas (2001) (183)
- Pancreatic fistula rate after pancreatic resection. The importance of definitions. (2004) (179)
- Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling (2014) (174)
- Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. (2012) (168)
- Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (162)
- Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis (2016) (160)
- Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study (2017) (159)
- High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. (2001) (158)
- Enucleation of pancreatic neoplasms (2007) (157)
- Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. (2012) (156)
- Italian consensus guidelines for chronic pancreatitis. (2010) (155)
- Neuroendocrine tumor disease: an evolving landscape. (2012) (147)
- High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma (2003) (142)
- Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial. (2018) (142)
- Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. (2009) (140)
- Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). (2013) (138)
- Cigarette Smoking: An Independent Risk Factor in Alcoholic Pancreatitis (1996) (138)
- (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial (2015) (138)
- Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study (2003) (137)
- Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. (2006) (136)
- Resectable Pancreatic Cancer: Who Really Benefits From Resection? (2009) (136)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation (2009) (135)
- Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. (2013) (134)
- The relevance of gastrointestinal fistulae in clinical practice: a review (2001) (134)
- Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases (2010) (132)
- MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. (2010) (131)
- Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. (1986) (130)
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma (2007) (128)
- Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases (2012) (124)
- Rare Functioning Pancreatic Endocrine Tumors (2006) (122)
- Systematic review of active surveillance versus surgical management of asymptomatic small non‐functioning pancreatic neuroendocrine neoplasms (2017) (121)
- Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. (2012) (119)
- Behavior of antibiotics during human necrotizing pancreatitis (1994) (119)
- Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. (2004) (116)
- Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. (2014) (112)
- Clinical and biological behavior of pancreatic solid pseudopapillary tumors: Report on 31 consecutive patients (2007) (110)
- Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. (2011) (109)
- Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors (2010) (109)
- Risk of death from acute pancreatitis (1996) (105)
- Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors (2004) (104)
- Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. (2013) (103)
- Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review (2011) (102)
- Long-term follow-up of patients with chronic pancreatitis in Italy. (1998) (101)
- “Paraduodenal” Pancreatitis: Results of Surgery on 58 Consecutives Patients from a Single Institution (2009) (101)
- Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q. (2001) (100)
- Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL (2001) (98)
- A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors (2018) (98)
- Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. (2016) (98)
- Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. (2016) (97)
- Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. (2006) (96)
- Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms (2002) (95)
- A multimodality test to guide the management of patients with a pancreatic cyst (2019) (94)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors (2009) (92)
- Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. (2012) (91)
- Real-world study of everolimus in advanced progressive neuroendocrine tumors. (2014) (91)
- Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes after Curative Resection of Ampulla of Vater Carcinoma (2008) (90)
- Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? (2016) (88)
- A systematic review on robotic pancreaticoduodenectomy. (2013) (86)
- Contrast-Enhanced Ultrasonography Better Identifies Pancreatic Tumor Vascularization than Helical CT (2005) (83)
- Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p (1998) (83)
- Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. (2007) (80)
- Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study. (2018) (80)
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management (2016) (80)
- Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization (2001) (80)
- Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. (2009) (79)
- Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1 (2013) (79)
- Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. (2012) (78)
- Microbiological findings in severe pancreatitis (1989) (78)
- Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. (2014) (77)
- Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67 (2018) (77)
- Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. (2009) (74)
- International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. (2016) (74)
- Endocrine neoplasms of the pancreas: pathologic and genetic features. (2009) (73)
- Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases (2015) (72)
- Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study (2018) (71)
- Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery (2016) (71)
- Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results (2012) (70)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors (2017) (70)
- Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach. (2014) (70)
- ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors (2010) (69)
- Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. (2021) (69)
- Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors (2014) (68)
- Smoking Cessation at the Clinical Onset of Chronic Pancreatitis and Risk of Pancreatic Calcifications (2007) (68)
- Invasive Intraductal Papillary Mucinous Carcinomas of the Pancreas: Predictors of Survival and the Role of Lymph Node Ratio (2010) (68)
- A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4‐Related Disease and Decreases Following Glucocorticoid Treatment (2018) (68)
- The determinant factors of recurrence following resection for ductal pancreatic cancer. (2007) (68)
- Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis. (2016) (68)
- Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors (2011) (67)
- Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.) (1993) (66)
- Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters. (2016) (66)
- Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors (2014) (66)
- Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior (2010) (65)
- Systematic review and meta-analysis of metal versus plastic stents for preoperative biliary drainage in resectable periampullary or pancreatic head tumors. (2016) (65)
- Retroperitoneal and peritoneal drainage and lavage in the treatment of severe necrotizing pancreatitis. (1990) (63)
- Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. (2006) (63)
- Anastomotic leakage in pancreatic surgery. (2007) (62)
- Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma (2007) (62)
- Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. (2014) (60)
- Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management (2017) (60)
- Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors (2011) (59)
- Pancreaticojejunostomy is comparable to pancreaticogastrostomy after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled trials (2016) (58)
- Somatostatin Receptor Subtypes 2 and 5 Are Associated with Better Survival in Well-Differentiated Endocrine Carcinomas (2008) (58)
- Surgical strategy in the treatment of pancreatic neuroendocrine tumors. (2006) (57)
- Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma (2012) (57)
- CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors (2021) (57)
- Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma (2003) (56)
- Current status of robotic distal pancreatectomy: a systematic review. (2013) (56)
- Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. (2004) (55)
- Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. (2020) (54)
- Prospective randomised pilot study of management of the pancreatic stump following distal resection (1999) (54)
- Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms (2017) (54)
- Endovascular Repair of 40 Visceral Artery Aneurysms and Pseudoaneurysms with the Viabahn Stent-Graft: Technical Aspects, Clinical Outcome and Mid-Term Patency (2018) (54)
- B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease. (2020) (53)
- Intraductal Papillary Mucinous Neoplasms and Chronic Pancreatitis (2007) (52)
- The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3 (2002) (52)
- Management of ampullary neoplasms: A tailored approach between endoscopy and surgery. (2015) (52)
- Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. (2015) (52)
- Sex chromosome anomalies in pancreatic endocrine tumors (2002) (52)
- Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries (2011) (51)
- Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence (2013) (51)
- Pancreatoblastoma in Adults: A Review of the Literature (2008) (51)
- Advanced Digestive Neuroendocrine Tumors: Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome (2014) (49)
- Neuroendocrine pancreatic tumor (2004) (49)
- Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1–G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases (2016) (49)
- Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. (1995) (49)
- Risk Factors for Sporadic Pancreatic Endocrine Tumors: A Case–Control Study of Prospectively Evaluated Patients (2009) (49)
- Early Postoperative Prediction of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: usefulness of C-reactive Protein. (2017) (49)
- Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease (2017) (48)
- Extent of surgical resections for intraductal papillary mucinous neoplasms. (2010) (48)
- Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis (2000) (48)
- Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. (1994) (48)
- Parenchyma-sparing resections for pancreatic neoplasms (2010) (48)
- Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study (2013) (48)
- Minimally Invasive Necrosectomy Versus Conventional Surgery in the Treatment of Infected Pancreatic Necrosis: A Systematic Review and a Meta-Analysis of Comparative Studies (2013) (47)
- Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. (2013) (47)
- Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study (2011) (47)
- Duodenal duplication cyst causing severe pancreatitis: imaging findings and pathological correlation. (2006) (46)
- The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution (2017) (45)
- Enhanced recovery pathways in pancreatic surgery: State of the art. (2016) (45)
- Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2 cm in MEN1 Patients (2016) (45)
- The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms. (2018) (45)
- Contrast‐Enhanced Ultrasonographic Detection of Small Pancreatic Insulinoma (2003) (45)
- Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma (2017) (45)
- A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma. (2018) (44)
- A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. (2019) (43)
- Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation. (2017) (43)
- Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis (2016) (43)
- Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? (2009) (43)
- Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms. (2016) (43)
- Long-term results of frey’s procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients (2006) (43)
- Ki-67 prognostic and therapeutic decision driven marker for pancreatic neuroendocrine neoplasms (PNENs): A systematic review. (2016) (43)
- Long-Term Outcome after Laparoscopic Bowel Resections for Deep Infiltrating Endometriosis: A Single-Center Experience after 900 Cases (2014) (42)
- Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. (2017) (42)
- Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship (2019) (42)
- Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. (2010) (42)
- Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms (2017) (41)
- Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases (2011) (41)
- Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome. (2017) (40)
- Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial. (2018) (40)
- Parenchyma-sparing resection for pancreatic neoplasms (2010) (40)
- Surgical Treatment of Pancreatic Metastases from Renal Cell Carcinomas (1998) (39)
- Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). (2017) (39)
- The Role of Combined 68Ga-DOTANOC and 18FDG PET/CT in the Management of Patients with Pancreatic Neuroendocrine Tumors (2014) (39)
- Pancreatic cystic manifestations in von Hippel-Lindau disease (1997) (39)
- Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma. (2016) (39)
- The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer (2019) (39)
- Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). (2001) (38)
- Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms (2018) (38)
- Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. (2007) (38)
- Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer (2020) (38)
- Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life. (2019) (38)
- A single-institution experience with fistulojejunostomy for external pancreatic fistulas. (2000) (38)
- Evaluation of a predictive model for pancreatic fistula based on amylase value in drains after pancreatic resection. (2014) (37)
- Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patients. (2016) (37)
- Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. (2020) (37)
- Epidemiology of Acute Pancreatitis (1987) (36)
- A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula (2021) (36)
- Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome – An International Consensus Statement (2020) (36)
- Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). (2020) (36)
- Open pancreaticogastrostomy after pancreaticoduodenectomy: A pilot study (2006) (36)
- Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse (2018) (36)
- Meta‐analysis of mortality in patients with high‐risk intraductal papillary mucinous neoplasms under observation (2018) (36)
- Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease. (2019) (36)
- Digestive and Liver Disease (2011) (35)
- Cytoreductive surgery in advanced endocrine tumours of the pancreas. (1999) (35)
- Endovascular Treatment of Visceral Artery Aneurysms and Pseudoaneurysms in 100 Patients: Covered Stenting vs Transcatheter Embolization (2017) (35)
- GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors. (2014) (35)
- Successful xenografting of cryopreserved primary pancreatic cancers (2001) (35)
- Imaging of neuroendocrine gastroenteropancreatic tumours (2010) (35)
- Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence. (2019) (35)
- Presentation and Outcome of Pancreaticoduodenal Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome (2011) (35)
- Early Detection of Pancreatic Cancer following the Diagnosis of Chronic Pancreatitis (1999) (35)
- Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? (2019) (35)
- Role of Chemoembolization in Synchronous Liver Metastases from Pancreatic Endocrine Tumours (1999) (34)
- Pain relapses in the first 10 years of chronic pancreatitis. (1996) (34)
- Right hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum. (2014) (34)
- Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. (2009) (34)
- Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection (2011) (33)
- Outcome of Open Necrosectomy in Acute Pancreatitis (2003) (33)
- Selection criteria in resectable pancreatic cancer: a biological and morphological approach. (2014) (33)
- Consensus guidelines update for the management of functional p-NETs (F-p-NETs) and non-functional p-NETs (NF-p-NETs) (2016) (33)
- Effectiveness of gabexate mesilate in acute pancreatitis (1995) (33)
- Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs) (2017) (32)
- Pancreatic acinar carcinoma shows a distinct pattern of chromosomal imbalances by comparative genomic hybridization (2000) (31)
- Management of Locally Advanced Pancreatic Cancer (2019) (31)
- Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review. (2016) (31)
- Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid) (2006) (31)
- Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology (2016) (31)
- Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms. (2018) (31)
- Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience (2018) (30)
- A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein. (2016) (30)
- Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry (2018) (30)
- Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. (2003) (30)
- Modelling centralization of pancreatic surgery in a nationwide analysis (2020) (29)
- Multimodal treatment of resectable pancreatic ductal adenocarcinoma. (2017) (29)
- A preoperative score to predict early death after pancreatic cancer resection. (2017) (29)
- Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? (2012) (28)
- Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside (2014) (28)
- Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma (2020) (28)
- Contrast‐Enhanced Ultrasonography in the Characterization of Pancreatic Mucinous Cystadenoma (2004) (28)
- Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study (2019) (28)
- Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications (2017) (27)
- Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma (2016) (27)
- Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. (2016) (27)
- Todani Type II Congenital Bile Duct Cyst: European Multicenter Study of the French Surgical Association and Literature Review. (2015) (27)
- Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease. (2019) (27)
- Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. (2007) (27)
- Resectable Pancreatic Adenocarcinoma: Depiction of Tumoral Margins at Contrast-Enhanced Ultrasonography (2008) (27)
- Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis. (2020) (26)
- Laparoscopic ileocecal resection for bowel endometriosis (2011) (26)
- Surgical Treatment of Pancreatic Tumors in Childhood and Adolescence: Uncommon Neoplasms with Favorable Outcome (2011) (26)
- Minimally Invasive Versus Open Treatment for Benign Sporadic Insulinoma Comparison of Short-Term and Long-Term Outcomes (2018) (26)
- Ultrasonography of the pancreas. 7. Intraoperative imaging (2007) (26)
- Defining Benchmark Outcomes for Pancreatoduodenectomy With Portomesenteric Venous Resection. (2020) (25)
- A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases. (2017) (25)
- Alcohol Intake, Cigarette Smoking, and Body Mass Index in Patients with Alcohol-associated Pancreatitis (2000) (25)
- Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians. (2010) (24)
- Changes in pancreatic resection for chronic pancreatitis over 28 years in a single institution (2000) (24)
- Isolated blunt duodenal trauma: delayed diagnosis and favorable outcome with "quadruple tube" decompression. (2007) (24)
- Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques, and Outcomes (2021) (24)
- Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study (2015) (24)
- Ciprofloxacin penetration in pancreatic juice. (1987) (24)
- Outcome and quality of life in chronic pancreatitis. (2001) (24)
- Contrast‐Enhanced Ultrasonography of Small Solid Pseudopapillary Tumors of the Pancreas (2005) (23)
- Antimicrobial activity of human pancreatic juice and its interaction with antibiotics (1996) (23)
- Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. (2013) (23)
- Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival (2013) (23)
- Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas. (2014) (22)
- Surgical management of neuroendocrine tumors. (2016) (22)
- Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors (2020) (22)
- Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making. (2015) (22)
- Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus. (2006) (22)
- mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors. (2016) (22)
- Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI (2013) (22)
- Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis. (2020) (22)
- Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study (2020) (22)
- Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours. (2001) (21)
- Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas (2013) (21)
- Quality assessment of the guidelines on cystic neoplasms of the pancreas. (2015) (20)
- Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. (2019) (20)
- DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors (2019) (20)
- "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. (2012) (20)
- Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest) (2021) (20)
- Medical treatment for gastro-entero-pancreatic neuroendocrine tumours. (2016) (20)
- Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors (2020) (20)
- Prophylaxis for septic complications in acute necrotizing pancreatitis. (2001) (20)
- A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways (2014) (20)
- Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs (2014) (20)
- Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment (2020) (20)
- Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience (2000) (19)
- Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion (2005) (19)
- Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma (2019) (19)
- Spectrum of magnetic resonance imaging findings in pancreatic and other abdominal manifestations of Von Hippel-Lindau disease in a series of 23 patients: a pictorial review. (2014) (19)
- R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma (2021) (19)
- Single-incision laparoscopic cholecystectomy versus traditional laparoscopic cholecystectomy performed by a single surgeon: findings of a randomized trial (2016) (19)
- Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms (2018) (19)
- Update on gastroenteropancreatic neuroendocrine tumors. (2020) (19)
- Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress (2022) (19)
- Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance (2021) (19)
- Chronic pancreatitis: relationship to acute pancreatitis and pancreatic cancer. (2000) (18)
- Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens (2019) (18)
- Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis (2018) (18)
- Necrosectomy by lavage in the surgical treatment of severe necrotizing pancreatitis. Results in 263 patients. (1990) (18)
- Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3. (2020) (18)
- Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study. (2018) (17)
- B-Cell Lymphoma Presenting as Acute Pancreatitis (2011) (17)
- Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) (2020) (17)
- Previous Cholecystectomy, Gastrectomy, and Diabetes Mellitus are not Crucial Risk Factors for Pancreatic Cancer in Patients with Chronic Pancreatitis (2001) (17)
- Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study (2019) (17)
- Pancreatic abscess and other pus-harboring collections related to pancreatitis: A review of 108 cases (1990) (17)
- Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. (2013) (17)
- Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery (2020) (17)
- Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop? (2005) (17)
- Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. (2013) (17)
- Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms. (2020) (16)
- Antibacterial and mezlocillin-enhancing activity of pure human pancreatic fluid (1991) (16)
- B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma (2020) (16)
- Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma (2016) (16)
- Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery. (1994) (16)
- Non-traumatic abdominal emergencies: imaging and intervention in acute pancreatic conditions (2002) (16)
- Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives. (2001) (16)
- Ofloxacin penetration into bile and pancreatic juice. (1989) (16)
- Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer. (2017) (15)
- Understanding the Meaning of Recovery to Patients Undergoing Abdominal Surgery. (2021) (15)
- Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. (2020) (15)
- Value of regional lymphadenectomy in pancreatic cancer. (2005) (15)
- Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? (2003) (15)
- Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) (2019) (14)
- A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy. (2020) (14)
- Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study (2016) (14)
- Management of rectosigmoid obstruction due to severe bowel endometriosis (2014) (14)
- Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms (2020) (14)
- Pancreatic enzyme replacement therapy after gastric resection: An update. (2018) (14)
- Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals (2019) (14)
- The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer. (2014) (14)
- Zalecenia ogólne dotyczące postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych) (2017) (14)
- Somatostatin analogues and pancreatic fistulas. (1996) (14)
- Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign? (2020) (14)
- Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis (2002) (13)
- A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy (2020) (13)
- A Multigenomic Liquid Biopsy Biomarker for Neuroendocrine Tumor Disease outperforms CgA and has Surgical and Clinical Utility. (2021) (13)
- Facing the Pancreatic Dilemma (1994) (13)
- Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial. (2004) (13)
- Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors. (2002) (13)
- Penetration of mezlocillin into pancreatic juice. (1986) (13)
- Development of a conceptual framework of recovery after abdominal surgery (2019) (13)
- Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer. (2020) (13)
- Cystic tumours of the pancreas: a review. (2001) (13)
- Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs (2019) (13)
- Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era (2020) (13)
- Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study. (2020) (13)
- Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management. (2020) (12)
- Borderline resectable pancreatic cancer: More than an anatomical concept. (2017) (12)
- Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting (2020) (12)
- The role of surgery in the major early complications of severe acute pancreatitis. (1997) (12)
- Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). (2017) (12)
- Treatment trends in metastatic pancreatic cancer patients: Is it time to change? (2011) (12)
- Postpancreatectomy Acute Pancreatitis (PPAP) (2021) (12)
- Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms (2021) (12)
- Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy. (2021) (12)
- Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results. (2010) (12)
- The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age. (2019) (12)
- CFTR mutations and IV58-5T prevalence in idiopathic chronic and acute recurrent pancreatitis (1998) (12)
- A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma (2000) (12)
- Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival (2019) (12)
- Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas (2002) (12)
- Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries. (2012) (11)
- Evaluation of UICC TNM classification for pancreatic cancer (1997) (11)
- Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort. (2021) (11)
- The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis (2021) (11)
- Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. (2012) (11)
- Pancreatic Adenocarcinoma: Improving Prevention and Survivorship. (2017) (11)
- In vivo Octreotide Administration Acutely Reduces Exocrine Granule Size in the Human Pancreas (2001) (11)
- Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study. (2020) (11)
- Intra-Arterial Chemotherapy for Stage-lll/IV Pancreatic Cancer (1997) (11)
- Pancreas: Insulinoma—new insights into an old disease (2009) (11)
- Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study. (2004) (11)
- Diagnostic strategy with a solid pancreatic mass. (2019) (11)
- RELIABILITY OF PREOPERATIVE PANCREATIC NEUROENDOCRINE TUMORS GRADING ON ENDOSCOPIC ULTRASOUND SPECIMENS: A SYSTEMATIC REVIEW WITH META-ANALYSIS OF AGGREGATE AND INDIVIDUAL DATA. (2022) (11)
- Surgical management of the pancreatic stump following pancreato-duodenectomy. (2016) (11)
- Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer. (2020) (11)
- Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey. (2020) (11)
- Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients. (2016) (11)
- Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm–neuroendocrine tumor (2020) (10)
- Pancreatic Adenocarcinoma: Improving Prevention and Survivorship. (2017) (10)
- Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis. (2021) (10)
- Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty. (2020) (10)
- Local treatment for focal progression in metastatic neuroendocrine tumors. (2019) (10)
- SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer. (2018) (10)
- Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis. (2019) (10)
- Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. (2002) (10)
- An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change? (2010) (10)
- Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial (2021) (10)
- Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms (2020) (10)
- Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study (2019) (10)
- Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses. (2015) (10)
- A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study † (2020) (10)
- Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) (2020) (10)
- Gabexate mesilate in the treatment of acute pancreatitis. (1995) (10)
- Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). (2017) (10)
- Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors (2022) (10)
- Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. (2008) (9)
- Review of the diagnosis and management of intraductal papillary mucinous neoplasms (2019) (9)
- Continuous peritoneal dialysis in acute experimental pancreatitis in dogs (1989) (9)
- Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (2016) (9)
- Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy (2021) (9)
- What preoperative assessment is necessary for insulinomas? Calculating the degree of waste: analysis of 29 cases. (2002) (9)
- miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA (2017) (9)
- Pancreaticoduodenal graft in the rat: an original microsurgical technique. (1989) (9)
- Pancreatic head mass, how can we treat it? Chronic pancreatitis: surgical treatment. (2000) (9)
- Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy (2021) (9)
- A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. (2021) (9)
- Surgical management of pancreatic neuroendocrine neoplasms (2014) (9)
- [Intermediate resection and distal pancreatectomy for benign neoplasms of the pancreas: comparison of postoperative complications and costs]. (2001) (9)
- Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms (2020) (9)
- Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). (2017) (9)
- Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms (2019) (8)
- Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival (2021) (8)
- Management of Digestive Tract Fistulas (1999) (8)
- Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS). (2020) (8)
- Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. (2004) (8)
- Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy? (2018) (8)
- Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study. (2020) (8)
- The natural history of a branch-duct intraductal papillary mucinous neoplasm of the pancreas. (2014) (8)
- Management of hepatic metastases of well/moderately differentiated neuroendocrine tumors of the digestive tract (2016) (8)
- RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features (2020) (8)
- Evaluation of lanreotide effects on human exocrine pancreatic secretion after a single dose: preliminary study. (2002) (8)
- Does the extent of lymphatic resection affect the outcome in pancreatic cancer? (1997) (8)
- Management of digestive tract fistulas. A review. (1999) (8)
- Is CA 19-9 a screening marker? (2009) (8)
- Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art (2016) (8)
- Evolving pancreatic cancer treatment: From diagnosis to healthcare management (2021) (8)
- New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer (2019) (7)
- Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome. (2016) (7)
- A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care. (2020) (7)
- Derivative Surgical Treatment (1994) (7)
- Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology. (2018) (7)
- Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making (2022) (7)
- Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy (2021) (7)
- Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome. (2018) (7)
- Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis. (2021) (7)
- Assessment and treatment of severe pancreatitis. Protease inhibitor. (1999) (7)
- To what extent is surgery superior to endoscopic therapy in the management of chronic pancreatitis? (1998) (7)
- Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 (2004) (7)
- Diabetes‐free survival after extended distal pancreatectomy and islet auto transplantation for benign or borderline/malignant lesions of the pancreas (2019) (7)
- Application of minimally invasive pancreatic surgery: an Italian survey (2018) (7)
- Main Duct Thresholds For Malignancy Are Different In Intraductal Papillary Mucinous Neoplasms Of The Pancreatic Head And Body-Tail. (2020) (7)
- Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis. (2021) (7)
- Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach (2021) (6)
- Symptomatic stone in the duodenum after gastrectomy. (2001) (6)
- Pancreaticoduodenectomy in octogenarians: The importance of "biological age" on clinical outcomes. (2021) (6)
- Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance. (2021) (6)
- Assessment and Treatment of Severe Pancreatitis (1999) (6)
- Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma (2020) (6)
- Early complications of severe acute pancreatitis (2001) (6)
- Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. (2020) (6)
- Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system (2021) (6)
- The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. (2021) (6)
- Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET). (2019) (6)
- The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. (2021) (6)
- Use of antibiotics in necrotizing pancreatitis (1996) (6)
- EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) (2021) (6)
- [Quality of life assessment in pancreatic carcinoma: results of an European multicentric study]. (1999) (6)
- Molecular targeted therapy in enteropancreatic neuroendocrine tumors: from biology to clinical practice. (2014) (6)
- High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures (2021) (6)
- Different reconstruction techniques after pancreatoduodenectomy do not affect clinical and patient reported outcomes. (2014) (6)
- Prospective study of the detection and treatment of small tumors of the head of the pancreas (1995) (6)
- Erratum: Real-world study of everolimus in advanced progressive neuroendocrine tumors (The Oncologist, (2014) 19, (966-974), 10.1634/theoncologist.2014-0037) (2015) (6)
- Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide (2020) (6)
- Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms. (2018) (6)
- Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non operative management (2017) (6)
- Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours (2017) (6)
- ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma (2021) (5)
- Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). (2017) (5)
- Improved survival after pancreatic re-resection of positive neck margin in pancreatic cancer patients. A systematic review and network meta-analysis. (2021) (5)
- Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports (2022) (5)
- How should incidental NEN of the pancreas and gastrointestinal tract be followed? (2018) (5)
- Improving cytological diagnosis of pancreatic cysts: Is it clinically necessary or just the latest fashion? (2010) (5)
- Urgent manifestations of immunoglobulin G4-related disease (2020) (5)
- The Role of Combined 68 Ga-DOTANOC and 18 FDG PET / CT in the Management of Patients with Pancreatic Neuroendocrine Tumors (2015) (5)
- Neuroendocrine tumours in 2016: Defining rules for increasingly personalized treatments (2017) (5)
- ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors (2022) (5)
- Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology. (2021) (5)
- Salvage Islet Auto Transplantation After Relaparatomy (2017) (5)
- The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy (2020) (5)
- IMPROVING DIAGNOSTIC ACCURACY AND APPROPRIATE INDICATIONS FOR SURGERY IN PANCREATIC CYSTIC NEOPLASMS: THE ROLE OF ENDOSCOPIC ULTRASOUND. (2022) (5)
- The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy. (2021) (5)
- Outcome of surgical resection after neoadjuvant peptide receptor radionuclide therapy (PRRT) for pancreatic neuroendocrine neoplasms: A case-matched analysis (2016) (5)
- Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment. (2022) (5)
- Reappraisal of a 2-Cm Cut-off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms (2019) (5)
- Surveillance of Cystic Lesions of the Pancreas: Whom and How to Survey (2018) (5)
- EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? (2021) (5)
- Nowotwory neuroendokrynne trzustki — zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych) (2017) (5)
- A review on surgery of gastro-entero-pancreatic neuroendocrine tumors (2014) (5)
- Real-world study of everolimus in advanced progressive neuroendocrine tumors. (2015) (5)
- Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. (2015) (5)
- Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial. (2022) (4)
- 68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks (2019) (4)
- Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: aA systematic review and meta-analysis. (2022) (4)
- The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis (2020) (4)
- Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers (2021) (4)
- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise (2022) (4)
- Prophylactic pylorus-preserving gastric transposition in unresectable carcinoma of the pancreatic head. (2004) (4)
- Early graft injuries after pancreatic transplantation in syngeneic rats. Cytoprotective effects of gabexate-mesilate. (1991) (4)
- Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification (2021) (4)
- Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms. (2017) (4)
- Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study. (2022) (4)
- 667 Risk and Protective Factors for Midgut Carcinoid Tumours: A Case-Control Study of Prospectively Evaluated Patients (2015) (4)
- Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. (2017) (4)
- Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives. (2006) (4)
- Hyperinsulinemic hypoglycemia associated with ectopic Cushing’s syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: Clinical implications of a rare association (2011) (4)
- Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease. (2021) (4)
- Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases (2022) (3)
- 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. March 11-13, 2015, Barcelona, Spain: Abstracts (2015) (3)
- Endoscopic ultrasound-guided gastrojejunostomy does not prevent pancreaticoduodenectomy after long-term symptom-free neoadjuvant treatment (2021) (3)
- Pancreatic serous cystadenoma related mortality is almost nil (2014) (3)
- Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in unresectable or borderline resectable pancreatic adenocarcinoma (2016) (3)
- Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer (2020) (3)
- Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study. (2022) (3)
- Limitations of Conservative Therapy of Pancreatic Fistulas (1992) (3)
- Results of a multicenter clinical trial of pefloxacin versus imipenem in severe pancreatitis (1998) (3)
- Clinical Usefulness of 18 F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced EnteroPancreatic Neuroendocrine Neoplasms (2018) (3)
- Impact of care pathway adherence on recovery following distal pancreatectomy within an enhanced recovery program. (2021) (3)
- A Single-center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors (2022) (3)
- Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma (2018) (3)
- Clinical Manifestations and Therapeutic Management (2003) (3)
- Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. (2022) (3)
- Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein (2022) (3)
- Pancreatic Ductal Adenocarcinoma: A New TNM Staging System is Needed! (2017) (3)
- Outcomes After Minimally Invasive Versus Open Total Pancreatectomy (2021) (3)
- Rifampicin concentrations in pancreatic juice. (1985) (3)
- Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies (2022) (3)
- 6557 POSTER Pancreatic Endocrine Carcinoma – Lymph Node Ratio and KI67 Are Predictors of Recurrence After Curative Resections (2011) (3)
- Resection in chronic pancreatitis: anastomosis with the jejunum or with the stomach? (2000) (3)
- Role of Somatostatin and Its Analogues in Gastrointestinal Fistulas, Ascites and Pancreatic Pseudocysts (1994) (3)
- Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). (2022) (3)
- Small undifferentiated pancreatic adenocarcinoma which mimics IPMN at imaging. (2009) (3)
- Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms. (2020) (3)
- Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? (2020) (3)
- The continuing challenge of gastrointestinal fistulae. (2000) (3)
- Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association. (2011) (3)
- Staging of pancreatic cancer: Suggestions for a simplified, reliable modification of the TNM classification system (1995) (3)
- Duodeno-jejunal or gastro-enteric leakage after pancreatic resection: a case–control study (2019) (3)
- [Gabexate mesilate vs gabexate mesilate combined with octreotide in the prevention of postoperative complications of pancreatic surgery: preliminary results]. (2001) (3)
- Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature (2021) (3)
- Octreotide in Preventing Complications from Pancreatic Surgery (1996) (3)
- Pancreatic fistula after pancreaticoduodenectomy—does surgical technique matter? (2020) (3)
- Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors. (2020) (3)
- Screening for pancreatic cancer-a compelling challenge. (2021) (3)
- Assessing prognosis of neuroendocrine neoplasms: Results of a collaborative multinational effort including over 10.000 european patients—The ENETS registry. (2018) (3)
- Pancreatic Surgery. (2015) (3)
- The Applicability of a Checklist for the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency (2020) (2)
- The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer (2022) (2)
- Double‐stapled anastomosis versus mucosectomy and handsewn anastomosis in ileal pouch‐anal anastomosis for ulcerative colitis or familial adenomatous polyposis (2014) (2)
- Nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors. (2016) (2)
- The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer (2020) (2)
- Pitfalls of Medical Treatment (1992) (2)
- Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? (2022) (2)
- Focus on pancreatic cancer. (2018) (2)
- Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study (2021) (2)
- Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial (2021) (2)
- Dpc-4 is expressed in virtually all primary and metastatic pancreatic endocrine tumors (2002) (2)
- Proclivity to Explore Locally Advanced Pancreas Cancer Is Not Associated with Surgeon Volume (2021) (2)
- No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay. (2018) (2)
- Which is the best pancreatic anastomosis? (2019) (2)
- Trial sequential analysis of randomized controlled trials on neoadjuvant therapy for resectable pancreatic cancer. (2022) (2)
- COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol (2020) (2)
- CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (2022) (2)
- Comparison of robot-assisted and laparoscopic minimally invasive approaches for pancreatic neuroendocrine neoplasms (2016) (2)
- B01*A randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in unresectable or borderline resectable pancreatic adenocarcinoma: the ghost regimen strikes back (2016) (2)
- Risk stratification in pancreatic neuroendocrine tumours: the role of combined 68Ga-DOTATOC and 18F-FDG PET/CT (2018) (2)
- Low-frequency of RABL3 pathogenetic variants in hereditary and familial pancreatic cancer. (2020) (2)
- ASO Author Reflections: Circulating Neuroendocrine Gene Transcripts (NETest): A Promising Biomarker for Pancreatic Neuroendocrine Tumours (PanNET) (2020) (2)
- Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient? (2019) (2)
- Implications of Increased Serum Amylase after Pancreaticoduodenectomy: Toward a Better Definition of Clinically Relevant Postoperative Acute Pancreatitis (2020) (2)
- Justifying vein resection with pancreatoduodenectomy. (2016) (2)
- Questions about branch-duct IPMNs with Sendai negative criteria. (2014) (2)
- Complications After Pancreaticoduodenectomy: Analysis of Risk Factors, Their Incidence, and Possible Prevention in Italy (1997) (2)
- A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs. (2022) (2)
- Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. (2022) (2)
- ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION VERSUS SURGICAL RESECTION FOR TREATMENT OF PANCREATIC INSULINOMA. (2023) (2)
- Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground (2021) (2)
- Drugs Inhibiting Exocrine Pancreatic Section (1992) (2)
- Routine molecular profiling in both resectable and unresectable pancreatic adenocarcinoma: relevance of cytological samples. (2022) (2)
- Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation (2022) (2)
- Clinical Manifestations and Therapeutic Management of Hyperfunctioning Endocrine Tumors (2003) (2)
- Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts--a shape shifting outlook into an increasingly recognized disease. (2012) (2)
- The impact of nutritional status on pancreatic cancer therapy (2022) (1)
- Pancreatic serous cystadenoma-related mortality is almost nil - results of a multinational study under the auspices of the International Association of Pancreatology and the European Pancreatic Club (2014) (1)
- Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons’ Perspectives on Current Use and Future Recommendations (2023) (1)
- EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case–control study (2022) (1)
- Development of an EORTC quality of life questionnaire for patients with pancreatic neuroendocrine tumours: phases 1-3 (2020) (1)
- PV-0118: Prognostic impact of presurgical Ca 19-9 level in pancreatic adenocarcinoma: a pooled analysis (2016) (1)
- Perspectives of International Association of Pancreatology (IAP)/European Pancreas Club (EPC) consensus review of guidelines for the future studies on clinical management of pancreatic cancer (2015) (1)
- Elevated neutrophil/lymphocyte ratio is a major predictor of survival in advanced pancreatic ductal adenocarcinoma patients (2014) (1)
- Rectal indomethacin to prevent post-ERCP pancreatitis. (2012) (1)
- 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS (2019) (1)
- Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy. (2022) (1)
- Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival (2017) (1)
- [Does locoregional chemotherapy improve survival in patients with non-resectable pancreatic carcinoma? Results of an open controlled study]. (2001) (1)
- The use of ace inhibitors influences the risk of progression of BD-IPMNs under follow-up. (2022) (1)
- ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival (2021) (1)
- PC.01.1: Endoscopic Ultrasound (EUS)-Guided Hybridtherm Ablation in Patients With Stage III Pancreatic Ductal Adenocarcinoma (PDAC): Prospective Single Center Cohort Study (2017) (1)
- [Clinical evolution of chronic pancreatitis and quality of life]. (2000) (1)
- Therapy for locoregional disease: pancreas (2018) (1)
- Tumor size correlates with grading in nonfunctioning pancreatic neuroendocrine tumors and is not age-dependent (2018) (1)
- Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management (2022) (1)
- Mutation and Polymorphism Report (2000) (1)
- Access to diagnostics and treatment of neuroendocrine tumors (NETs): The difference between patient perception and reality. (2019) (1)
- Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression (2022) (1)
- Pancreatic Neuroendocrine Neoplasms (pNENs) (2015) (1)
- Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours. (2022) (1)
- Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review. (2004) (1)
- P.10.7 THE VALUE OF (18)FDG-PET/CT IN PATIENTS WITH RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY (2013) (1)
- Role of Minimally Invasive Surgery in the Treatment of Pancreatic Neuroendocrine Tumors (2018) (1)
- Interim Analysis of Prospective Evaluation of the Management of Sporadic Nonfunctioning Asymptomatic Pancreatic Neuroendocrine Neoplasms ≤ 2 cm ASPEN (Study) (2020) (1)
- Giant Brunner's gland adenoma (2007) (1)
- Nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors (2016) (1)
- How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery (2022) (1)
- Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study (2018) (1)
- Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach (2021) (1)
- Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm? (2017) (1)
- Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma (2022) (1)
- Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy (2022) (1)
- 967 Main-Duct and Combined IPMNs Are the Same Clinical Entity and Distinct from Branch-Duct IPMNs (2009) (1)
- Does Pancreatic Fat Really Really Matter In Determining Post-Operative Pancreatic Fistula? (2020) (1)
- The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms (2018) (1)
- Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study (2022) (1)
- Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms. (2022) (1)
- Behavior ofAntibiotics during HumanNecrotizing Pancreatitis (1994) (1)
- Clinical and economic validation of grade B postoperative pancreatic fistula subclassification. (2021) (1)
- P.03.15 APPLICABILITY OF A CHECKLIST FOR THE DIAGNOSIS AND TREATMENT OF SEVERE EXOCRINE PANCREATIC INSUFFICIENCY (EPI). PRELIMINARY RESULTS OF AN EPI ITALIAN REGISTRY (EPITALY) (2019) (1)
- Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma (2020) (1)
- Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire. (2022) (1)
- OP0167 B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE (2019) (1)
- Risk factors for the occurrence of ampullary tumors: A case‐control study (2022) (1)
- Comment on "predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine". (2014) (1)
- Pancreatic metastasis of papillary thyroid carcinoma with an intraductal growth pattern (2020) (1)
- Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module) (2022) (1)
- Pancreatic Endocrine Tumors (2009) (1)
- Is surgery an option after downstaging of liver metastases from pancreatic cancer following primary chemotherapy (2015) (1)
- Early postoperative prediction of clinically relevant pancreatic fistula after pancreaticoduodenectomy (2016) (1)
- Adjuvant chemotherapy in patients with resected pancreatic cancer following neoadjuvant FOLFIRINOX chemotherapy: an international multicenter study (2020) (1)
- Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. (2013) (1)
- Pharmacokinetics of metronidazole (MZ) in patients with pancreatic fistula. (1987) (1)
- PO-0707: The impact of dose on survival in adjuvant chemoradiation pancreatic cancer (2016) (1)
- Incidental histological diagnosis of small pancreatic neuroendocrine tumors: are we underestimating their incidence? (2018) (0)
- Pancreatic cancer-associated diabetes is correlated with increased liver nitric oxide (NO) (2002) (0)
- Early reccurrence after resection for pancreatic cancer: the importance of surgical related factor and tumour biology (2020) (0)
- P.113 RISK AND PROTECTIVE FACTORS FOR MIDGUT CARCINOID TUMOURS: MULTICENTER CASE-CONTROL STUDY OF PROSPECTIVELY EVALUATED PATIENTS (2010) (0)
- EPC Society News (2002) (0)
- Acknowledgement to the Reviewers (2009) (0)
- Minimally invasive approaches for pancreatic neuroendocrine neoplasms: Comparing robot-assisted and laparoscopic approaches (2015) (0)
- Rifampicin concentrations in pancreatic juice [letter] (1985) (0)
- Predictors and Patterns of Recurrence after Surgery for Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Implications for Follow-up Strategy (2020) (0)
- T03.01.7 EARLY RECCURRENCE AFTER RESECTION FOR PANCREATIC CANCER: THE IMPORTANCE OF SURGICAL RELATED FACTOR AND TUMOUR BIOLOGY (2020) (0)
- Pancreaticoduodenectomy for pancreatic neuroendocrine neoplasms: incidence, risk and predictors of postoperative morbidity and mortality (2019) (0)
- Prevention of sepsis in acute pancreatitis (1996) (0)
- Roleofsomatostatin andsomatostatin analogues inthetreatmentofgastrointestinal diseases: preventionofcomplications afterpancreatic (1994) (0)
- Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours. (2022) (0)
- T1743 Quality of Life in Long-Term Survivors After Pancreaticoduodenectomy (2008) (0)
- A multidisciplinary approach to familial pancreatic cancer enriches the proportion of patients with genetically confirmed pancreatic cancer susceptibility (2018) (0)
- 297. Radiomic CT features of pancreatic neuroendocrine tumors are robust against inter-observer delineation uncertainty (2018) (0)
- P.18.5 INFLAMMATORY AND NUTRITIONAL STATUS AT DIAGNOSIS AFFECT THE PROGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA REGARDLESS THE STAGE OF DISEASE (2014) (0)
- Consensus on medical treatments for pancreatic neuroendocrine tumors (2016) (0)
- Chapter 15 PiUalls of Medical Treatment (1992) (0)
- RISK FACTORS FOR PANCREATIC ENDOCRINE TUMOURS: A MULTICENTER CASE-CONTROL STUDY (2008) (0)
- Prognostic factors in patients with pancreatic metastases from renal cell carcinoma (PM-RCC): Room for thinking about the role of surgery? (2014) (0)
- Prognostic role of the parenchymal frozen transection margin during pancreaticoduodenectomy for ductal pancreatic adenocarcinoma (2018) (0)
- Specific features of Endoscopic Ultrasound with contrast-enhancement and elastography allow the differential diagnosis between focal autoimmune pancreatitis and pancreatic adenocarcinoma (2020) (0)
- [Integrated project for the translational research on pancreatic ductal carcinoma]. (2002) (0)
- Quality of Life After Pancreaticoduodenectomy Using Different Reconstruction Techniques: A Follow-up Multicenter Study (2012) (0)
- Perineural Invasion in Pancreatic Ductal Adenocarcinoma (2018) (0)
- Subject Index Vol. 6, 2006 (2007) (0)
- ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer (2022) (0)
- OC-0455 MULTIVARIATE PREDICTION OF FOLLOW-UP OUTCOME FOR PATIENTS WITH PANCREATIC CANCER: A POOLED DATA ANALYSIS (2012) (0)
- Survival in Patients Aged 75 Years and Older Receiving Adjuvant Chemoradiation for Resected Pancreatic Adenocarcinoma: A Multicenter, Multinational Pooled Analysis (2015) (0)
- ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer (2022) (0)
- 113. Small intestinal neuroendocrine tumours with liver metastases and resection of the primary: Prognostic factors for decision making (2014) (0)
- Vascular resections during pancreatectomy for pancreatic cancer: a technical issue or a prognostic sign? (2020) (0)
- Alagille Syndrome and the Notch Signaling Pathway: New Insights Into Human Development (1999) (0)
- Factors associated with delayed discharge in patients undergoing pancreatic surgery within an enhanced recovery pathway (2017) (0)
- Contribution of endosonography (EUS) to the diagnosis of duodenal duplication in adults: Case reports (2000) (0)
- Twice-weekly gem and concurrent RT in patients with advanced pancreatic cancer (2006) (0)
- ESPAC Satellite Symposium (1997) (0)
- Somatostatin analogs: is one better than other? (2017) (0)
- Non-Adenocarcinoma Pancreatic Tumors (2001) (0)
- Biological role of perineural invasion in pancreatic ductal cancer (2019) (0)
- Discoid Resection With Combined Laparoscopic/Endoscopic Approach for Rectal Endometriosis: Perioperative and Long-Term Outcomes (2011) (0)
- P.10.1 HETEROGENEITY OF DUODENAL NEUROENDOCRINE TUMORS: A MULTI-CENTRE EXPERIENCE IN ITALY (2018) (0)
- Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. (2011) (0)
- AB053. P024. Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma: does it have a prognostic role? (2018) (0)
- A new scoring system to predict recurrent disease in grade 1 and 2 non-functional pancreatic neuroendocrine tumors (2019) (0)
- President’s Address at the General Assembly by John Wong, President CICD (1999) (0)
- ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? (2021) (0)
- 77INDO MINIMAL ACCESS AND ROBOTIC SURGERY BRING BENEFIT TO NEUROENDOCRINE TUMOURS? (2014) (0)
- ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma (2020) (0)
- Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects (2022) (0)
- Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) (2023) (0)
- Abstract 3401: Impact of VEGF and VEGFR polymorphisms on neuroendocrine tumors of the gastro-entero-pancreatic system (GEPNETs) outcome (2016) (0)
- Pattern and clinical predictors of lymph node involvement in neuroendocrine neoplasms of the pancreas (2012) (0)
- Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors (2021) (0)
- MP41-16 DECIPHERING THE RELATIONSHIP BETWEEN PATHOGENIC VARIANTS AND CLINICAL PHENOTYPE IN VHL PATIENTS: RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY (2023) (0)
- 43 Long-Term Outcomes of IPMNs With Consensus Guidelines Criteria for Resection Undergoing Nonoperative Management (2015) (0)
- Long-term comparison of conservative management versus surgery for nonfunctioning pancreatic neuroendocrine tumors less than 2 cm affecting patients with men1 syndrome (2016) (0)
- The number of positive nodes accurately predicts recurrence after distal pancreatectomy for nonfunctioning neuroendocrine neoplasms (2020) (0)
- Procedure terapeutiche (Pancreas) (2008) (0)
- Islet autotransplantation as a safe procedure in patients with malignancy (2015) (0)
- Prognostic impact of preoperative serum CA 19-9 level in pancreatic cancer: a pooled analysis (2017) (0)
- Spleen-preserving pancreatic resections with preservation of splenic vessels: A cautionary note on the risk of vascular complications (2016) (0)
- Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. (2003) (0)
- T03.01.23 IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH HYBRIDTHERM PROBE IN STAGE III PANCREATIC DUCTAL ADENOCARCINOMA: PRELIMINARY RESULTS FROM A PHASE II/III RANDOMIZED-CONTROLLED TRIAL (2020) (0)
- Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors. (2023) (0)
- Abstracts from the sixth meeting of the international association of pancreatology, November 2–4, 1994, Chicago, IL (1994) (0)
- University of Groningen A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms (2020) (0)
- M1544 Quality of Life After Total Pancreatectomy: Requiem for a Surgical Dogma? (2008) (0)
- OC.13.1 ASSOCIATION OF GERMLINE GENE MUTATIONS IN EARLY ONSET GASTROINTESTINAL CANCERS WITH NEGATIVE FAMILY HISTORY (2018) (0)
- Australasian Pancreatic Club (APC) and Sydney Upper Gastrointestinal Surgical Society (SUGSS) Joint Meeting (2011) (0)
- OC.03.7 ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH HYBRIDTHERM PROBE IN ADDITION TO CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR THE TREATMENT OF LOCALLY ADVANCED OR BORDERLINE RESECTABLE PANCREATIC CANCER: A PHASE II RANDOMIZED CONTROLLED TRIAL (2021) (0)
- Chapter 14 Limitations of Conservative Therapy of Pancreatic Fistulas (1992) (0)
- Subject Index Vol. 18, 2001 (2002) (0)
- Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status (2011) (0)
- Long-term safety of islet autotransplantation in patients with malignancy (2016) (0)
- Subject Index Vol. 7, 2007 (2007) (0)
- MULTIFOCAL BRANCH-DUCT IPMNS: A NEW DEAL TO BE EXPLORED (2006) (0)
- Initial Experiences of an Enhanced Recovery Programme After Pancreaticoduodenctomy (2013) (0)
- Gabexate Mesilate and Acute Pancreatitis (1994) (0)
- Downstaging of liver metastases from pancreatic cancer following primary chemotherapy: A new indication for surgery? (2016) (0)
- Contents Vol. 18, 2001 (2001) (0)
- Necrosectomy and Closed Lavage in Acute Pancreatitis (1993) (0)
- Abstract 3455: Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up (2015) (0)
- Minimally invasive versus open treatment for benign sporadic insulinoma Comparison of short term and long term outcomes (2018) (0)
- Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment. (2022) (0)
- A randomized phase II trial on neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma (2018) (0)
- Pancreatic Decompression in Chronic Pancreatitis (2004) (0)
- AB065. P037. Prognostic role of the parenchymal frozen transection margin during pancreaticoduodenectomy (PD) for ductal pancreatic adenocarcinoma (2018) (0)
- P.05.7 SYSTEMATIC REVIEW AND META-ANALYSIS OF STUDIES COMPARING METAL OR PLASTIC STENTS FOR PREOPERATIVE BILIARY DRAINAGE IN RESECTABLE PANCREATIC CANCER (2016) (0)
- Subject Index Vol. 60, 1999 (1999) (0)
- Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. (2023) (0)
- Quality of life in chronic pancreatitis (2012) (0)
- Establishment of a cryopreserved tissue bank and a xenografting facility for pancreatic cancer (2000) (0)
- Positive neck margin at frozen section analysis is a significant preditor of tumour recurrence and poor survival after pancreatoduodenectomy for pancreatic cancer (2020) (0)
- Diagnosis of Infected Pancreatic Necrosis (1997) (0)
- Pefloxacin penetration during acute pancreatitis. (1994) (0)
- Management and clinical out come of patients with MEN 1 disease presentino Non Functioning Pancreatic neuroendocrine Neoplasms (NF- p NEN) < 2 cm (2015) (0)
- Staging digestive neuroendocrine tumors (dNETs): Comparative role of somatostatin receptors scintigraphy and helical CT (hCT) (2000) (0)
- Total pancreatectomy: how, when and why? (2021) (0)
- Metastatic pattern differently affects progression-free survival in pancreatic neuroendocrine tumors (2012) (0)
- Chapter 13 Drugs Inhibiting Exoerine Panereatie Seetion (1992) (0)
- 6636 POSTER Pancreatic Exocrine Insufficiency in Advanced Pancreatic Cancer -Fecal Elastase-1 (FE-1) Value Is a Strong Independent Predictor of Poor Survival (2011) (0)
- Abstract 3519: TGF-β pathway alteration in pancreatic neuroendocrine tumors: characterization of a novel SMAD3 translocation (2017) (0)
- Cancer of the papilla of Vater: preoperative cryostatic examination of endoscopic biopsies to reduce risk and save time and money (1995) (0)
- Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis (2022) (0)
- Influence of the dose on the penetration of mezlocillin (M) into human pancreatic juice (P.J.). (1987) (0)
- Subject Index Vol. 11, 1994 (1994) (0)
- How useful is somatostatin at reducing complications associated with pancreatic surgery? (2006) (0)
- OC.07.2: Pancreatic Cystic Neoplasms of the Pancreas: Results of the Enrollment Phase of Pancreatic Cyst (PANCY) Study (2017) (0)
- Dual tracer 68Ga-DOTATOC and 18F-FDG PET/CT for preoperative risk evaluation in pancreatic neuroendocrine tumours: explorative texture analysis (2019) (0)
- EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting. (2023) (0)
- The impact of minimally invasive surgery on hospital readmissions and functional recovery after distal pancreatectomy. (2020) (0)
- The natural history of a large multicenter cohort of patients with “low-risk” BD-IPMNs (2020) (0)
- [Pancreatic cancer]. (2016) (0)
- OC.06.7 RISK OF MISDIAGNOSIS AND OVERTREATMENT IN PATIENTS WITH MAIN PANCREATIC DUCT DILATATION AND SUSPECTED COMBINED/MAIN-DUCT IPMNS (2016) (0)
- Volume-Outcome Relationship in Pancreatic Surgery (2020) (0)
- 50. Neuroendocrine tumours (2015) (0)
- Endocrine-Related Cancer ( 2012 ) 19 R 163 – R 185 Neuroendocrine tumor disease : an evolving landscape (2012) (0)
- Guideline for the Management of Pancreatic Neuroendocrine Tumor (2017) (0)
- OC.09.5 SIZE AND SITE OF MAIN PANCREATIC DUCT DILATION CORRELATES WITH DISTINCT RISK OF MALIGNANCY IN MAIN-DUCT/ MIXED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS (2020) (0)
- Laparoscopic extended versus open extended distal pancreatectomy for ductal adenocarcinoma: A pan-European propensity-score matched study (2020) (0)
- P.116 APPLICATION OF “PANCPRO” TO SELECT FAMILIES ELIGIBLE TO SCREENING FOR PANCREATIC CANCER (2010) (0)
- ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors. (2023) (0)
- ENETS News Letter (2015) (0)
- Adjuvant chemoradiation in pancreatic cancer (2015) (0)
- Multivisceral resection for pancreatic ductal adenocarcinoma of the body and tail: Is it worth? A multicentre retrospective analysis from Western European countries (2022) (0)
- Nones, K. et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT- (2014) (0)
- Contents, Vol. 58, 1997 (1997) (0)
- OC.08.6 THE USE OF ACE INHIBITORS AND STATINS IS ASSOCIATED WITH A SLOWER PROGRESSION OF BD-IPMNS IN FOLLOW-UP (2019) (0)
- Early Postoperative Outcomes After Laparoscopic Segmental Colorectal Resection for Endometriosis: The Impact of Surgical Experience (2011) (0)
- Contents Vol. 100, 2014 (2015) (0)
- OC.01.6 INCIDENTAL DIAGNOSIS AS PROGNOSTIC FACTOR IN DIFFERENT TUMOR STAGES OF NON-FUNCTIONING PANCREATIC ENDOCRINE TUMORS (2013) (0)
- Pancreatic Pathology (Special Topics) (2005) (0)
- Clinical Aspect of Complications: Features and Prognoses (2009) (0)
- The spectrum of Intraductal tumours (2000) (0)
- Preliminary Microbiological and Antibiotic Kinetic-study On Prevention and Treatment of Pancreatic Infections (1986) (0)
- Results of Non-Operative Management for Intraductal Papillary Mucinous Neoplasms with High-Risk Stigmata or Worrisome Features: A Systematic Review and Meta-Analysis (2017) (0)
- Hormonal Treatment of Pancreatic Fistulas (1993) (0)
- Intraductal mucinous papillary neoplasms and chronic pancreatitis (2006) (0)
- T03.01.12 LONG-TERM EFFICACY OF MAINTENANCE THERAPY WITH RITUXIMAB FOR IGG4-RELATED AUTOIMMUNE PANCREATITIS (2020) (0)
- Role of TGF[beta]1 in pancreatic neuroendocrine tumour (2015) (0)
- Pancreatic Cystic Tumors : Verona Centre Experience. (2003) (0)
- Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy. (2022) (0)
- Acknowledgement to the Reviewers (2015) (0)
- Il carcinoma pancreatico (2016) (0)
- 1034: ANALYSIS OF RECURRENCE FOLLOWING POST-NEOADJUVANT PANCREATECTOMY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA (2022) (0)
- The Italian National Registry for minimally invasive pancreatic surgery: an initiative of the Italian Group of Minimally Invasive Pancreas Surgery (IGoMIPS) (2020) (0)
- Sistematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer (2017) (0)
- Tu1784 The Presence of Abdominal Complications is an Independent Predictor of Poor Survival After Resection for Pancreatic Cancer (2012) (0)
- Geographic variation in attitudes regarding management of locally advanced pancreatic cancer (2022) (0)
- Results of non-operative management for intraductal papillary mucinous neoplasms with an indication for surgery: A meta-analysis (2016) (0)
- Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients. (2010) (0)
- Reappraisal of a 2 cm cut-off size for the management of cystic pancreatic neuroendocrine neoplasms: A multicenter international study (2019) (0)
- Correction to: Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy (2021) (0)
- 39 – Age, Obesity, Diabetes and Initial Cyst Size are Associated with the Risk of Progression of Bd-Ipmn Undergoing Follow-Up (2019) (0)
- Assessment of the external validity of a predictive model based on amylase value in drains for fistula risk after pancreaticoduodenectomy (2016) (0)
- Su1463 Risk of Pancreatic Malignancies in Patients With Branch-Duct IPMN Undergoing Follow-Up: Systematic Review and Meta-Analysis (2015) (0)
- EP-1250: Prognostic impact of post-surgery and postadjuvant therapy in resected pancreatic adenocarcinoma (2017) (0)
- Establishment and characterization of a vitally cryopreserved tissue bank for pancreatic cancer. Vol. 41 (2000) (0)
- Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer. (2023) (0)
- Cystic distrophy of the duodenal wall (CDDW): The verona experience (2000) (0)
- Minutes of the 3rd General Assembly of European Digestive Surgery (EDS) (1999) (0)
- clinical practice guidelines Pancreatic cancer : ESMO Clinical Practice Guidelines for diagnosis , treatment and follow-up (2010) (0)
- Radiomics and pancreatic tumors: a new tool for old problems (2020) (0)
- Surgical and Interventional Perspective in Chronic Pancreatitis (2009) (0)
- Contents Vol. 6, 2006 (2007) (0)
- ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (2022) (0)
- Diagnosis and Differential Diagnosis of Pancreatic Cystic Tumors (2007) (0)
- The prognostic value of C-reactive protein in a new preoperative clinical risk score for survival after surgery for sporadic, non-functioning pancreatic neuroendocrine neoplasia: An international multicentre study (2020) (0)
- How should we go about staging cancer in the future (1996) (0)
- Impact of postoperative complications on long-term survival after resection of pancreatic ductal adenocarcinoma (2016) (0)
- Subject Index Vol. 91, 2010 (2010) (0)
- P-0114 Advances in The Treatment of Resectable Pancreatic Cancer: Lessons Learned from two Decade (2012) (0)
- Age, obesity, diabetes and initial cyst size are associated with the risk of progression of BD-IPMN undergoing follow-up (2019) (0)
- A tug-of-war in IPMN management: a comparison between 2017 International and 2018 European guidelines (2019) (0)
- The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma. (2023) (0)
- OC.09.4 PANCREATOBILIARY MANIFESTATIONS DIFFERS FROM OTHER IGG-RELATED DISEASE PHENOTYPES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS, AND PROGNOSTIC OUTCOMES (2020) (0)
- The impact of preoperative anemia on pancreatic resection outcomes. (2021) (0)
- Clinical management and predictors of malignancy in patients with ipmns with worrisome features (2020) (0)
- Laparoscopic Colorectal Surgery for Bowel Endometriosis With Transvaginal Resection and Specimen Extraction: Perioperative Results in 40 Consecutive Patients (2011) (0)
- Management of functioning endocrine pancreatic tumors. (2003) (0)
- Author response to: Modelling centralization of pancreatic surgery: some additional considerations (2020) (0)
- Initial Experience with Robot-Assisted Distal Pancreatectomy for Pancreatic Neuroendocrine Neoplasms (2015) (0)
- Implications of perineural invasion on disease recurrence and survival following pancreatectomy for pancreatic head ductal adenocarcinoma (2019) (0)
- PC.01.6 A MULTIDISCIPLINARY APPROACH TO FAMILIAL PANCREATIC CANCER ENRICHES THE PROPORTION OF PATIENTS WITH GENETICALLY CONFIRMED PANCREATIC CANCER SUSCEPTIBILITY (2018) (0)
- Non Functional Pancreatic Neuroendocrine Tumors (2021) (0)
- MP28-16 GENERALIZABILITY OF THE MK-6482-004 TRIAL TO REAL-WORLD VHL PATIENTS: RESULTS FROM A PROSPECTIVE SURVEILLANCE STUDY (2023) (0)
- Cystic Adenoma of the Pancreas - Diagnosis and Surgical-treatment (1987) (0)
- Diagnostic Accuracy of Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA) in the Evaluation of Pancreatic Neuroendocrine Neoplasms (pNEN) Grading (2020) (0)
- Outcome of patients with IPMN and an indication for surgery according with the Sendai guidelines who only receive a conservative management (2013) (0)
- Contents Vol. 93, 2011 (2011) (0)
- Pancreatic Neuroendocrine Tumours (2018) (0)
- OC.08.3 METASTATIC PATTERN DIFFERENTLY AFFECTS SURVIVAL IN DIGESTIVE NEUROENDOCRINE TUMORS (2012) (0)
- Is main pancreatic duct dilation really an independent risk factor for malignancy in main-duct and combined-IPMNs? (2018) (0)
- Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET) (2020) (0)
- Reply to "Stratifying the risk of IPMNs: don't rule out the EUS toolkit". (2021) (0)
- Delayed post-pancreatectomy hemorrhage after left pancreatectomy: Incidence, risk factors and unusual clinical presentations (2016) (0)
- Resection in Cancer: Lymph Node Dissection (1999) (0)
- Contents Vol. 11, 2011 (2012) (0)
- Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in metastatic pancreatic adenocarcinoma. (2017) (0)
- Sa1389 Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms (2016) (0)
- Multicenter survey of antibiotic prophylaxis in surgery (1987) (0)
- AB017. S017. Is main pancreatic duct dilation really an independent risk factor for malignancy in main-duct and combined-IPMNs? (2018) (0)
- A Solid Mass in the Head of the Pancreas with Intense 18FDG Uptake: Intraductal Tubulopapillary Neoplasm (2013) (0)
- Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: from guidelines to real life (2019) (0)
- T03.01.4 STATIN USE IMPROVES SURVIVAL IN PATIENTS WITH PDAC: A META-ANALYSIS (2020) (0)
- Indicators of survival in patients treated with primary chemotherapy for non-metastatic pancreatic adenocarcinoma (2017) (0)
- Advances in the treatment of resectable pancreatic cancer. Lessons learned from two decade (2012) (0)
- Mo1744 - Association of Germline Gene Mutations in Early Onset Gastrointestinal Cancers with Negative Family History (2018) (0)
- Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors (2022) (0)
- Fully hybrid 68Ga-DOTATOC PET/MRI in NET patients: synergic value of 68Ga-DOTATOC PET and MRI (2020) (0)
- SELECTING FAMILIES ELIGIBLE TO SCREENING FOR PANCREATIC CANCER: APPLICATION OF A MENDELIAN MODEL TO A LARGE SERIOES OF CONSECUTIVE CASES (2008) (0)
- AB0985 Methotrexate as induction of remission therapy for localized manifestations of IGG4-related disease (2017) (0)
- Evolution of knowledge about pancreatic cystic neoplasms: A bibliometric analysis. (2022) (0)
- THU0038 Increase of circulating memory b cells after glucocorticoid-induced remission identifies patients at risk of igg4-related disease relapse (2018) (0)
- Table I, Early complications in SAP (within the first 2 weeks) (2001) (0)
- OC.09.2 A PROSPECTIVE REAL-LIFE PANCREATIC CYST (PANCY) SURVEY CARRIED OUT IN ITALY REGARDING THE CLINICAL DIAGNOSIS AND DIAGNOSTIC BURDEN OF CYSTIC NEOPLASMS OF THE PANCREAS (2020) (0)
- Geographic Variation in Attitudes Regarding Locally Advanced Pancreatic Cancer Management (2021) (0)
- Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: a propensity score-matched cohort (2022) (0)
- Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors FRANCESCOPANZUTO, a MARIARINZIVILLO, a NICOLAFAZIO, b FILIPPODEBRAUD, c GABRIELELUPPI, d MARIACHIARAZATELLI, e FRANCESCALUGLI, f (2014) (0)
- Blood neuroendocrine gene transcripts (NETest) as a diagnostic of pancreatic neuroendocrine tumors and to identify the efficacy of surgical resection. (2020) (0)
- Contents, Vol. 33, 1987 (1987) (0)
- EUS versus CT scan in establishing the T stage in surgically resected pancreatic cancer based on the new TNM 8th edition (2018) (0)
- Exploring optimal therapeutic management of STAGE IA PDAC in the era of neoadjuvant chemotherapy. (2023) (0)
- Same-session Double EUS-bypass versus Surgical Gastroenterostomy and Hepaticojejunostomy: An International Multicenter Comparison. (2023) (0)
- Neuroendocrine Tumors Management of hepatic metastases of well / moderately differentiated neuroendocrine tumors of the digestive tract (2016) (0)
- Low grade IPMNs: A test of conscience (2020) (0)
- Diameter of surgical versus endoscopic ultrasound-guided gastrojejunostomy: that much wider after all is said and done? (2021) (0)
- 781 Tissue and Serum Levels of Substance P Correlate in Patients with Chronic Pancreatitis (2008) (0)
- Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway (2022) (0)
- W1406 Risk Factors for Pancreatic Endocrine Tumors: Multicentre Case-Control Study (2008) (0)
- Association between preoperative vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET) (2019) (0)
- P.09.4 PANCREATIC EXOCRINE INSUFFICIENCY IN ADVANCED PANCREATIC CANCER: FAECAL ELASTASE-1 (FE-1) VALUE IS A STRONG INDEPENDENT PREDICTOR OF POOR SURVIVAL (2012) (0)
- Impact of adherence to enhanced recovery pathway interventions on recovery following distal-pancreatectomy. (2020) (0)
- Mtor inhibitors responsiveness associates with Akt/Mtor pathway activation in pancreatic neuroendocrine tumors (2016) (0)
- T03.01.8 LONG-TERM PANCREATIC FUNCTIONAL IMPAIRMENT AFTER SURGERY FOR NEUROENDOCRINE NEOPLASMS (2020) (0)
- Prognostic role of resection margins after pancreatectomy for adenocarcinoma of the head of the pancreas (2020) (0)
- PO-1225 Hypofractionated radiotherapy after induction chemotherapy for advanced pancreatic cancer (2021) (0)
- Early graft injurie, after pancreatic transplantation insyngeneic rats (1991) (0)
- CS3.2 LONG TERM FOLLOW-UP OF AUTOIMMUNE PANCREATITIS (2008) (0)
- A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. (2007) (0)
- A randomized phase 2 trail of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in unresectable or borderline resectable pancreatic adenocarcinoma: the ghost regimen strikes back (2017) (0)
- Acknowledgement to Reviewers (2007) (0)
- T03.01.6 DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING (2020) (0)
- Consensus assessment : Imaging and Biomarkers in Gastroenteropancreatic 1 Neuroendocrine Tumour Disease Management (2016) (0)
- Anastomotic leakeage in pancreatic surgery (2007) (0)
- Sa1371 – Eus and Ct Scan Diagnostic Yield in Establishing the T Stage in Surgically Resected Pancreatic Cancer Based on the Tnm 8Th Edition (2019) (0)
- Cancer of the Exocrine Pancreas: Surgery and Multimodal Treatment (2009) (0)
- How clinical presentation of insulinoma is changing (2012) (0)
- Response to Malleo et al. (2017) (0)
- T03.01.14 THE ITALIAN REGISTRY OF FAMILIES AT RISK OF PANCREATIC CANCER (IRFARPC) INTRODUCES A TOOL TO RECRUIT INDIVIDUALS AND TO INCREASE PANCREATIC CANCER PREDISPOSITION AWARENESS: THE IRISK APP (2020) (0)
- Evaluation of a Predictive Model for Pancreatic Fistula Based on Amylase Value in Drains: A Prospective Study on 231 Consecutive Patients (2012) (0)
- Duodenojejunal or gastroenteric leakage after pancreatic resection: A case control study (2018) (0)
- Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity (2020) (0)
- Contents Vol. 91, 2010 (2010) (0)
- Clinical Strategy In Severe Hemorrhage Due To Pancreatic Pseudocysts (1986) (0)
- Prognostic role of a novel clinical-nutritional index in pancreatic ductal adenocarcinoma: The Pancreatic Adenocarcinoma Nutritional-Clinical Index (PANCIN). (2023) (0)
- Is Enucleation Safe When the Distance Between the Tumor and the Main Pancreatic Duct Is Less Than 3 mm? Results from a Multi-Institutional Retrospective Study (2012) (0)
- 37th Annual Meeting of the American Pancreatic Association and 13th Meeting of the International Association of Pancreatology. November 1–4, 2006, Chicago, Ill. (2007) (0)
- External validation of the VHL alliance guidelines for VHL genetic testing in patients diagnosed with renal cell carcionoma (2021) (0)
- Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians (2022) (0)
- Surgical Therapy of Pancreatic Neuroendocrine Neoplasms (2015) (0)
- Antibiotics Secretion into Pancreatic Fluid (1992) (0)
- Contents (2020) (0)
- ASO Visual Abstract: Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (2022) (0)
- Re: “Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer” (Surg Endosc (2010) 24:1:63–67) (2013) (0)
- Minimally Invasive Pancreatectomy plus Islet Autotransplantation for Benign Tumors of the Pancreatic Neck and Body (2018) (0)
- Natural History of Small Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors: An Observational Bi-Centric Study (2013) (0)
- New Surgical Strategies (2021) (0)
- Acute necrotising pancreatitis and fistula treatment: The role of Somatostatin-14 and its analogues (2002) (0)
- B27Pathogenic and prognostic role of VEGF and VEGFR single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine neoplasms (2016) (0)
- [Closed surgical treatment in acute severe pancreatitis]. (1995) (0)
- Variation in the surgical management of locally advanced pancreatic cancer. (2019) (0)
- Site and size of MPD dilation in determining malignant degeneration of IPMNs. (2020) (0)
- Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi survey (2020) (0)
- Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review (2023) (0)
- Increase of circulating memory B cells after glucocorticoid-induced Remission identifies patients at risk of IgG4-related autoimmune pancreatitis relapse (2018) (0)
- Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies. (2022) (0)
- Postoperative outcomes and functional recovery after neoadjuvant chemotherapy for pancreatic cancer: A propensity score-matched study (2020) (0)
- 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
- Prevention of complications after pancreatic surgery TABLE I Postoperative complications used to evaluate octreotide efficacy in comparison with placebo Death * Leakage from anastomosis Pancreatic fistula Abscess Fluid collection Pancreatitis Shock Sepsis Respiratory failure Renal failure Bleeding * (0)
- Incidental histological diagnosis of small pancreatic neuroendocrine tumours: Are we underestimating their incidence? (2018) (0)
- Sa1458 DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING (2020) (0)
- 827PRENAL METASTASES TO PANCREAS: DO NOT OPERATE ALL AND ALWAYS? (2014) (0)
- 6556 POSTER Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail – a Novel Prognostic Parameter for Patients Selection (2011) (0)
- Islet autotransplantation: Indication beyond chronic pancreatitis (2020) (0)
- Surgery of Neuroendocrine Tumors 2 (2014) (0)
- Imipenem (IMP) penetration into pancreatic tissue during acute necrotizing form (NP). (1991) (0)
- [Chronic pancreatitis]. (1970) (0)
- Does the risk of postoperative complications affect the adherence to enhanced recovery pathways after pancreaticoduodenectomy (2017) (0)
- Sa1476 IMMUNOMODULATION INDUCED BY ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH THE HYBRIDTHERM PROBE IN STAGE III PANCREATIC DUCTAL ADENOCARCINOMA: SINGLE-CENTER PRELIMINARY RESULTS FROM A PHASE II/III RANDOMIZED-CONTROLLED TRIAL (2020) (0)
- Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy (2023) (0)
- Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma. (2023) (0)
- ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? (2022) (0)
- SP-0657 Against the motion: resectable pancreatic cancer (2019) (0)
- [Chronic pancreatitis]. (1970) (0)
- QUALITY OF LIFE IN SUBJECTS WHO UNDERWENT PANCREATIC HEAD RESECTION: THE INTERIM REPORT OF A MULTICENTER STUDY (2007) (0)
- Genome-wide allelotyping of pancreatic acinar cell and non-functional endocrine tumors (2000) (0)
- T03.01.5 AGE, OVERWEIGHT, DIABETES AND INITIAL CYST SIZE ARE ASSOCIATED WITH THE RISK OF PROGRESSION OF BD-IPMN UNDERGOING FOLLOW-UP (2020) (0)
- Reassessment of proliferative activity at disease progression in neuroendocrine neoplasms (2016) (0)
- W1137 Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients (2010) (0)
- 1st National Congress of the Hellenic Society of Digestive Surgery (2004) (0)
- Contents Vol. 103, 2016 (2016) (0)
- How to Deal with a Periampullary Mass (2003) (0)
- Type of reconstruction after pancreaticoduodenectomy : where are we going? An attempt of answer in a single high volume centre (2005) (0)
- 2021 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Las Vegas, Nevada, 31 August–3 September 2021: Videos (2021) (0)
- ENETS Newsletter Summer/Fall 2012 (2012) (0)
- Author and Subject Index (1999) (0)
- 9th Meeting of the Spanish Bilio-Pancreatic Club (2006) (0)
- T03.01.15 SECOND PRIMARY NEOPLASMS IN PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): DATA FROM A RETROSPECTIVE IT.A.NET STUDY (2020) (0)
- Questions About Branch-Duct IPMNs With (2013) (0)
- Subject Index Vol. 58, 1997 (2004) (0)
- EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case–control study (2022) (0)
- Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT (2020) (0)
- Post-operative NETest scores detect residual NET disease and accurately predicts tumor recurrence in R0 (2020) (0)
- T03.01.9 PANCREATOBILIARY MANIFESTATIONS REPRESENT THE MAJOR CAUSE OF REFERRAL TO THE EMERGENCY DEPARTMENT IN PATIENTS WITH IGG4-RELATED DISEASE (2020) (0)
- Erratum: Outcome and quality of life in chronic pancreatitis (Journal of the Pancreas (Online) (2001) vol. 2 (4) (117-123)) (2005) (0)
- P.08.5: Endoscopic Ultrasound Appearance of Pancreatic Serotonin-Staining Neuroendocrine Neoplasms: A Case Series (2017) (0)
- T03.01.1 A TUG-OF-WAR IN IPMNS MANAGEMENT: A COMPARISON BETWEEN 2017 INTERNATIONAL AND 2018 EUROPEAN GUIDELINES (2020) (0)
- Cystic Pancreatic Tumors (2012) (0)
- Perioperative outcomes after pancreaticoduodenectomy for neuroendocrine neoplasms: A comparison with pancreatic ductal adenocarcinoma (2016) (0)
- Resectability of Pancreatic Cancer Is in the Eye of the Observer (2021) (0)
- Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up. (2016) (0)
- The Value of 18FDG-PET/CT in Patients with Resectable Pancreatic Cancer: A Prospective Study (2012) (0)
- Teicoplanin concentrations in cholecystic, pancreatic and hepatic tissues (1987) (0)
- 898 Is a « Watch and Wait » Strategy Justified in Patients With Small Non-Functioning Pancreatic Neuroendocrine Tumors ? (2013) (0)
- Contents Vol. 7, 2007 (2007) (0)
- P.04.1: Results of Non-Operative Management for Intraductal Papillary Mucinous Neoplasms with an Indication for Surgery: A Systematic Review and Meta-Analysis (2017) (0)
- Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence. (2023) (0)
- Ability of surgery to cure patients with entero-pancreatic endocrine tumors (2006) (0)
- OC.08.2 POORLY DIFFERENTIATED RESECTABLE PANCREATIC CANCER: AN INDICATION FOR NEOADJUVANT TREATMENT? (2012) (0)
- Tumor size but not margin status is an indipendent prognostic factor for body/tail ductal adenocarcinoma after distal pancreatectomy (2020) (0)
- Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure? (2023) (0)
- Applicability of a Checklist for the Diagnosis and Treatment of Severe Exocrine Pancreatic Insufficiency (EPI). Preliminary results of an EPI Italian Registry (EPItaly) (2019) (0)
- OC.09.1 B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS (2020) (0)
- Role of Dose on Survival in Adjuvant Chemoradiation Pancreatic Cancer (2015) (0)
- OC.09.3 CIRCULATING NEUROENDOCRINE GENE TRANSCRIPTS (NETEST): A POSTOPERATIVE STRATEGY FOR EARLY IDENTIFICATION OF THE EFFICACY OF RADICAL SURGERY FOR PANCREATIC NEUROENDOCRINE TUMOURS (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Massimo Falconi?
Massimo Falconi is affiliated with the following schools:
